P M Lalley, G V Rossi, W W Baker. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Acetylcholine/adverse effectsAnimalsBasal Ganglia/drug effectsBrain/physiopathologyCarbachol/adverse effectsCatsCholinesterase Inhibitors/adverse effectsDisease Models, AnimalDopamine/adverse effectsDrug AntagonismDrug SynergismEpinephrine/adverse effectsHemicholinium 3/adverse effectsIsoflurophate/adverse effectsKetones/adverse effectsMaleOximes/adverse effectsPentobarbital/adverse effectsPhysostigmine/adverse effectsPralidoxime Compounds/adverse effectsReceptors, Drug/drug effectsScopolamine/adverse effectsTremor/chemically inducedTremor/physiopathology
Substances： See more » Cholinesterase InhibitorsKetonesOximesPralidoxime CompoundsReceptors, DrugIsoflurophateHemicholinium 3CarbacholPhysostigmineScopolaminePentobarbitalAcetylcholineDopamineEpinephrine
Year: 1970 PMID： 5424588 DOI： 10.1016/0014-4886(70)90219-0
Source DB: PubMed Journal: Exp Neurol ISSN： 0014-4886 Impact factor: 5.330